CARM

Carisma Therapeutics, Inc.

HealthcareBiotechnologyUSUSDPeers →via fmp_bulk

$0.01

LiveJun 22, 2026

Market cap

$418.45K

52w range

0.00 – 0.56

P / E

—

EPS

—

Volume

1.11K

Revenue · FY

—

Explain this page

Arphra AIPlain-English read on Carisma Therapeutics, Inc.’s valuation

Enterprise value

-$1.22M

Market cap

$795.06K

Net debt

—

Total debt

—

Cash & ST inv.

—

Capital structure

· balance sheet · 2026-06-20

Market capitalisation$795.06K

+ Total debt+—

− Cash & short-term investments−—

= Enterprise value-$1.22M

Valuation

· key metrics · TTM

EV / EBITDA-0.1×

EV / Sales-0.0×

EV / FCF0.1×

Net debt / EBITDA-0.1×

Debt / Equity—

Arphra AIPlain-English read on the EV build & leverage